Regulatory Roundup for the Week of February 4, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup for the Week of February 4, 2013

ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA has released Guidance on Photosafety Evaluation of Pharmaceuticals S10, Step 2 Version (Nov. 13, 2012). This guidance recommends international standards for photosafety assessment, and harmonization of such assessments supporting human clinical trials and marketing authorization for pharmaceuticals.

In the effort to resolve the shortage of the cancer drug Doxil, FDA has approved the generic version of doxorubicin hydrochloride liposome injection, made by Sun Pharma Global FZE (Sun).

The European Medicines Agency and the Japanese Ministry of Health, Labour and Welfare (MHLW) have launched a public consultation on a joint reflection paper on the development of block-copolymer-micelle medicinal products.

The United States Pharmacopeia has announced the formation of three new Expert Committees for its Medicines Compendium (MC) and an expanded and enhanced website for the online-only compendium in response to the need for global public quality standards for medicines.

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) launched a public health campaign in partnership with pharmacy organizations to promote the need for the public reporting of suspected side effects from drugs through MHRA’s Yellow Card Scheme.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here